Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Chris Lazarini Comments on Monopolization Claims Under Sherman and Clayton Acts

Securities Litigation Commentator


July 18, 2016

Bass, Berry & Sims attorney Chris Lazarini commented on a case in which a group of sophisticated individual commodities traders alleged that JP Morgan manipulated prices in the silver futures spreads market, creating a monopoly and forcing Plaintiffs out of the market. The Court dismissed the claims for several reasons, including the Plaintiffs' failure to prove that JP Morgan had willfully acquired or maintained its monopoly power under the Sherman and Clayton Acts.

Chris provided the analysis for Securities Litigation Commentator (SLC). The full text of the analysis is below and used with permission from the publication. If you would like to receive additional content from the SLC, please visit the SLC website to sign up for the newsletter.

Shak vs. JP Morgan Chase & Co., No. 15-civ-992, -994 & -995 (S.D. N.Y., 6/29/16) 

To state a claim for monopolization under §2 of the Sherman Act and §4 of the Clayton Act, plaintiffs must allege: (1) the possession of monopoly power in the relevant market; (2) the willful acquisition or maintenance of that power as distinguished from growth or development of the power through superior product development, business acumen, or historic accident; and (3) damage flowing from the monopoly. 

In these consolidated cases, a group of sophisticated individual commodities traders ("Plaintiffs") alleged that JP Morgan manipulated prices in the silver futures spreads market, creating a monopoly and forcing Plaintiffs out of the market. On JP Morgan's motion to dismiss, the Court initially dismissed with prejudice Plaintiffs' claims under the Commodities Exchange Act, New York General Business Law, and for unjust enrichment as untimely. The Court also dismissed Plaintiffs' Sherman Act, Clayton Act and state antitrust claims for failure to state a claim, but granted leave to amend those claims.

After Plaintiffs filed their amended complaint, attempting to elaborate on the mechanics of the alleged monopolization scheme, JP Morgan moved to dismiss. The Court first notes that the amended complaint adequately alleged that JP Morgan possesses monopoly power in the silver futures spreads market, because the market essentially consisted of JP Morgan on one side and Plaintiffs, a few lower capitalized, vulnerable proprietary traders, on the other.

The Court next considers whether Plaintiffs' allegations of predatory bidding and manipulation of the COMEX settlement committee plausibly state a claim that JP Morgan willfully acquired or maintained its monopoly power. Plaintiffs alleged that JP Morgan bid up the cost of silver futures far beyond any legitimate price, causing an unnatural rise in the price of silver spreads and making it impossible for Plaintiffs to continue trading. Plaintiffs also alleged that JP Morgan pressured a COMEX representative to settle at prices JP Morgan dictated, as opposed to prices reflective of where the market had been trading. The Court is skeptical about Plaintiffs' predatory bidding theory, because other courts have found it inapplicable to futures market cases. The Court ultimately finds the amended complaint lacking in sufficient detail about the alleged predatory bidding to state a plausible claim.

The Court takes a similarly dim view of the claims of improper pressure on the COMEX settlement committee, finding the allegations contradictory. On each day the amended complaint alleges JP Morgan's representations to COMEX did not reflect where the market had been trading that day, the Court explains, the amended complaint also alleges there was no trading that day. The Court rejects Plaintiffs' efforts in the alternative to rely on a one-year futures pricing benchmark in establishing prices for the three-year market transactions at issue, finding a lack of correlation between the two. Finally, the Court finds Plaintiffs' statements regarding JP Morgan's alleged motive to be conclusory and lacking sufficient detail to state a claim. Finding no basis for allowing another amendment, the Court dismisses the claims with prejudice.

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.